WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ
REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L'EUROPE
WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО
First Regional Consultation on Viral /2
Hepatitis in the WHO European Region:
Progress on the Way to Elimination
Tbilisi, Georgia 19 November 2018
12–13 February 2019 Original: English
Scope and purpose
Background
Viral hepatitis is a global public health threat which, until recently, has not received adequate attention.
An estimated 15 million people in the WHO European Region are living with chronic hepatitis B virus
infection and 14 million are estimated to be living with chronic hepatitis C virus infection. In addition,
about 171 000 people die from viral hepatitis-related causes in the Region every year.
In September 2016, the 66th session of the Regional Committee of the WHO Regional Office for Europe
(RC66) has endorsed the first ever Action plan for the health sector response to viral hepatitis in the
WHO European Region. The Action plan guides Member States in accelerating the response to the viral
hepatitis epidemics at national level to contribute to the regional and global efforts to eliminate viral
hepatitis as a public health threat by 2030. The goals and targets are supported by the 2030 Agenda for
Sustainable Development, the Global Health Sector Strategies on HIV and Viral Hepatitis for the period
2016–2021, and Health 2020, the European policy framework for health and well-being.
Since its adoption, the Action plan has served as a ground for accelerated response in many Member
States through development of national strategies and action plans. Unprecedented reductions in prices of
medicines for the treatment of chronic hepatitis just over few last years triggered rapid increase in access
to these life-saving medicines and creating the demand for policy revision and optimising service
delivery models that would allow expanding coverage with prevention, testing and treatment
interventions necessary to achieve the ambitious goals of elimination.
WHO Regional Office for Europe is set to report to the 69th session of the Regional Committee on the
mid-term progress of the Action plan implementation.
In addition, in 2015-2018 WHO released a full set of normative guidelines covering surveillance and
strategic information, testing, care and treatment of chronic hepatitis B and C, and provides support to
countries in formulating and implementing policies and programmes to improve and scale up viral
hepatitis services for all people in need.
Scope and purpose
The meeting is aimed at reviewing the countries’ progress, challenges and exchange good practices to
overcome them in response to viral hepatitis, including national planning, surveillance and monitoring,
prevention, testing and strengthening laboratory capacity, improving access to diagnostics and treatment
and optimizing viral hepatitis management strategies in line with the updated WHO guidelines.
Scope and purpose
page 2
Objectives
1. Take stock of countries’ progress in implementation the Action plan for the health sector response to
viral hepatitis in the WHO European Region (2016).
2. Provide a platform for exchange the good practices in scaling up and improving health sector
response to viral hepatitis in the Member States for WHO European Region.
3. Review and exchange the latest evidence, WHO guidance, tools and policies, including developed by
partners, viral hepatitis strategic information and response.
Expected results and Outputs
• An overview of the status of the comprehensive national response to viral hepatitis in the Member
States of the WHO European Region
• Representatives of Member States, partner organizations and other stakeholders updated about the
latest scientific and public health developments and current WHO guidelines, as well about the
good practices in the health sector response to viral hepatitis in Member States of the WHO
European Region
• A meeting report prepared by the WHO Regional Office for Europe and published on-line, which
should inform the progress repost being prepared got the 69th Session of the WHO Regional
Committee (September 2018)
Event Format
The meeting is envisaged as a regional consultation with nominated representatives of all WHO/Europe
Member States and participation of regional partners and leading experts. The meeting will consist of
plenary sessions, a poster session and parallel sessions on defined topics. The agenda will be developed
to align with latest developments in science and public health but also responds to the needs of the
Member States of the WHO European Region.
Participants
Participants include:
• Two nominated representatives of each Member States of the WHO European Region: 1)
representative from the Ministry of Health responsible for viral hepatitis and 2) technical viral
hepatitis programme manager;
• European Commission (DG SANTE) and its agencies: ECDC and EMCDDA, and relevant UN
agencies;
• Representatives of professional associations, including EASL and ESCMID, WHO Collaborating
Centres and other invited experts;
• Civil society organisations, including hepatitis patients’ representatives;
• Representatives from WHO Country Offices, Regional Office and Headquarters.
Saatja: Triin Uusberg <
[email protected]>
Saadetud: 03.01.2019 14:41
Adressaat: Mall Hiet <
[email protected]>
Teema: FW: First Regional Consultation on viral Hepatitis - request for nominations
CRM:0056843
Manused: Hep_Nomination ltr_ESTONIA.pdf; Scope and purpose.pdf; Provisional agenda.pdf
Palun registreerida.
Aitäh.
Triin
From: Olga Fradkina <
[email protected]>
Sent: Wednesday, January 2, 2019 6:42 PM
To: Jürgen Ojalo <
[email protected]>
Cc: Andre Pung <
[email protected]>; Marge Reinap <
[email protected]>; Märt Volmer
<
[email protected]>; Triin Uusberg <
[email protected]>
Subject: First Regional Consultation on viral Hepatitis - request for nominations CRM:0056843
Please see the attached correspondence sent from the World Health Organization, Regional
Office for Europe. One or more attachments may be included.
Veuillez vous référer à la correspondance ci-jointe du Bureau régional de l'Europe de
l'Organisation mondiale de la santé. Une ou plusieurs annexes peuvent être jointes.
Mit der Bitte um Kenntnisnahme der beiliegenden Korrespondenz (eine oder mehrere Anlagen),
Weltgesundheitsorganisation, Regionalbüro für Europa
См. прикрепленные письма от Европейского регионального бюро Всемирной организации
здравоохранения (один или несколько прикрепленных файлов).
WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ
REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L'EUROPE
WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО
First Regional Consultation on Viral /3
Hepatitis in the WHO European Region:
Progress on the Way to Elimination
Tbilisi, Georgia 19 November 2018
12–13 February 2019 Original: English
Provisional agenda
1. Opening and welcome session
Plenary Session on the Progress Reports for the Global Health Sector Strategy and the
2.
Action plan for the health sector response to viral hepatitis in the WHO European Region
3. Plenary Session and poster session on viral hepatitis national planning
Parallel sessions on viral hepatitis surveillance and monitoring & evaluation (EU/EEA
4.
and non-EU/EEA)
Plenary sessions on viral hepatitis prevention interventions:
1) immunization and prevention of perinatal transmission of hepatitis B
5.
2) prevention of hepatitis C transmission among people who inject drugs and other
vulnerable populations
6. Plenary sessions and working groups on viral hepatitis testing and treatment
Parallel sessions on access to hepatitis medicines (for countries with access to generic
7.
medicines and without)
8. Wrap up session
9. Closing session